Therios 300 mg Palatable Tablets for Dogs

Main information

  • Trade name:
  • Therios 300 mg Palatable Tablets for Dogs
  • Available from:
  • Sogeval SA
  • Prescription type:
  • POM-V
  • Medicine type:
  • Veterinary

Localization

  • Available in:
  • United Kingdom
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Dogs

Status

  • Source:
  • VMD
  • Authorization date:
  • 2009-02-27

Documents

9-12-2015

Orphan designation: Imatinib mesilate, for the: Treatment of myelodysplastic / myeloproliferative diseases

On 23 December 2005, orphan designation (EU/3/05/340) was granted by the European Commission Novartis Europharm Limited, United Kingdom, for imatinib mesilate for the treatment of myelodysplastic / myeloproliferative diseases. Please note that this product was withdrawn from the Community Register of designated orphan medicinal products in April 2012 on request of the sponsor.

Europe - EMA - European Medicines Agency

31-7-2015

Nosodes and children's cough, cold and flu homeopathic products Labelling Changes

OTTAWA – Health Canada is advising consumers that it is introducing label changes for certain homeopathic products that fall under the Natural Health Product Regulations (NHPR). Current labelling on some homeopathic products may not provide Canadians with the information they need to make informed choices. The changes apply to the labelling of some homeopathic products, specifically nosode products as well as homeopathic cough, cold and flu products for children 12 and under.

Canada - Health Canada

31-7-2015

Gluconorm (repaglinide) - New Contraindication for Concomitant Use with Clopidogrel

Key messages Co-administration of repaglinide and clopidogrel (a CYP2C8 inhibitor) may lead to a significant decrease in blood glucose levels due to a drug-drug interaction. The concomitant use of repaglinide and clopidogrel is now contraindicated. The prescriber information for GLUCONORM (repaglinide) has been updated. The prescriber information for PLAVIX (clopidogrel) is currently being updated. The prescriber information for the generic products will be updated (see Products affected).

Canada - Health Canada

31-7-2015

Ceftazidime for Injection, USP (2015-07-27)

Canada - Health Canada

30-7-2015

ANSES: a brief outline

Created on 1 July 2010, the French Agency for Food, Environmental and Occupational Health & Safety (ANSES) is an independent scientific body which performs its risk assessment, reference and research activities in the fields of food safety and animal and plant health. Its core activity is the assessment of health risks in order to enable the public authorities to make informed decisions and in so doing to help ensure the health and safety of of the population both in its working and consumer activiti...

France - Agence Nationale du Médicament Vétérinaire

30-7-2015

Marketing authorisations of plant protection products, fertilisers and growing media, and their adjuvants

In compliance with the criteria defined by the European regulations, ANSES has been in charge of the appraisal of plant protection products, fertilisers and growing media, and adjuvants since 2006. Based on our scientific assessment of the risks and efficacy of these products, the Ministry of Agriculture issues marketing authorisations (MAs). Since 1 July 2015, in application of the French law on the future of agriculture, food and forestry of 13 October 2014, ANSES is in charge of issuing, withdrawing a...

France - Agence Nationale du Médicament Vétérinaire

29-7-2015

Scientific Opinion on Dietary Reference Values for phosphorus

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies derived Dietary Reference Values (DRVs) for phosphorus. The Panel considered data from balance studies, losses of phosphorus from the body and intestinal absorption for possible use in a factorial approach, and studies on phosphorus intake and long-term health outcomes. The Panel concluded that these data were insufficient for setting D...

Europe - EFSA - European Food Safety Authority EFSA Journal

29-7-2015

Scientific Opinion on the safety and efficacy of Biosprint(R) (Saccharomyces cerevisiae MUCL 39885) for minor ruminant species for meat and milk production

EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) Biosprint® is a zootechnical feed additive consisting of a dried preparation of a strain of Saccharomyces cerevisiae. It is already authorised for use in feed for piglets, cattle for fattening, dairy cows, horses and sows. The applicant has now requested that the product be authorised for use as a zootechnical additive (functional group: gut flora stabilisers) in diets for dairy buffaloes, dairy sheep and dairy go...

Europe - EFSA - European Food Safety Authority EFSA Journal

29-7-2015

Scientific Opinion on Dietary Reference Values for magnesium

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies (NDA) derived Dietary Reference Values (DRVs) for magnesium. The Panel considers that Average Requirements (ARs) and Population Reference Intakes (PRIs) for magnesium cannot be derived for adults, infants or children, and therefore defines Adequate Intakes (AIs), based on observed intakes in healthy populations in the European Union (EU...

Europe - EFSA - European Food Safety Authority EFSA Journal

28-7-2015

Conclusion on the peer review of the pesticide risk assessment of the active substance thifensulfuron-methyl

European Food Safety Authority The conclusions of the European Food Safety Authority (EFSA) following the peer review of the initial risk assessments carried out by the competent authority of the rapporteur Member State the United Kingdom, for the pesticide active substance thifensulfuron-methyl are reported.  The context of the peer review was that required by Commission Regulation (EU) No 1141/2010 as amended by Commission Implementing Regulation (EU) No 380/2013. The conclusions were reach...

Europe - EFSA - European Food Safety Authority EFSA Journal

28-7-2015

Scientific Opinion on Flavouring Group Evaluation 208 Revision 1 (FGE.208Rev1): Consideration of genotoxicity data on representatives for 10 alicyclic aldehydes with the α,β-unsaturation in ring / side-chain and precursors from chemical subgroup 2.2 of

EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF) The EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids was requested to evaluate the genotoxic potential of flavouring substances from subgroup 2.2 of FGE.19 in the Flavouring Group Evaluation 208 Revision 1 (FGE.208Rev1). The Flavour Industry has provided additional genotoxicity studies on p-mentha-1,8-dien-7-al [FL-no: 05.117], the representative substance for FGE.19 subgroup 2.2. T...

Europe - EFSA - European Food Safety Authority EFSA Journal

28-7-2015

Modification of the existing maximum residue levels for fenoxycarb in peaches and olives

European Food Safety Authority In accordance with Article 6 of Regulation (EC) No 396/2005, the evaluating Member State (EMS), France, received an application from Syngenta Agro S.A.S. to modify the existing maximum residue levels (MRLs) for the active substance fenoxycarb in peaches and olives. In order to accommodate for the intended uses of fenoxycarb, France proposed to raise the value of the existing MRL of 1 mg/kg (both peaches and olives) to 1.5 mg/kg in peaches and 3.0 mg/k...

Europe - EFSA - European Food Safety Authority EFSA Journal

28-7-2015

Reasoned opinion on the review of the existing maximum residue levels (MRLs) for acrinathrin according to Article 12 of Regulation (EC) No 396/2005

European Food Safety Authority According to Article 12 of Regulation (EC) No 396/2005, the European Food Safety Authority (EFSA) has reviewed the Maximum Residue Levels (MRLs) currently established at European level for the pesticide active substance acrinathrin. In order to assess the occurrence of acrinathrin residues in plants, processed commodities, rotational crops and livestock, EFSA considered the conclusions derived in the framework of Regulation (EC) No 1107/2009 as well as the Europe...

Europe - EFSA - European Food Safety Authority EFSA Journal

27-7-2015

Orphan designation: Obinutuzumab, for the: Treatment of marginal zone lymphoma

Europe - EMA - European Medicines Agency

27-7-2015

Orphan designation: Obinutuzumab, for the: Treatment of follicular lymphoma

Europe - EMA - European Medicines Agency

27-7-2015

Orphan designation: Trehalose, for the: Treatment of spinocerebellar ataxia

Europe - EMA - European Medicines Agency

21-7-2015

Safety of 2'-<i>O</i>-fucosyllactose as a novel food ingredient pursuant to Regulation (EC) No 258/97

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on 2'-O-fucosyllactose as a novel food ingredient (NFI) submitted pursuant to Regulation (EC) No 258/97 of the European Parliament and of the Council, taking into account the comments and objections of a scientific nature raised by Member States. 2'-O-fucosyllactose (2'-FL) is a synthetic tr...

Europe - EFSA - European Food Safety Authority EFSA Journal

21-7-2015

Safety of lacto-<i>N</i>-neotetraose as a novel food ingredient pursuant to Regulation (EC) No 258/97

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on lacto-N-neotetraose as a novel food ingredient (NFI) submitted pursuant to Regulation (EC) No 258/97 of the European Parliament and of the Council, taking into account the comments and objections of a scientific nature raised by Member States. Lacto-N-neotetraose (LNnT) is a synthetic ...

Europe - EFSA - European Food Safety Authority EFSA Journal

21-7-2015

Scientific Opinion on the substantiation of a health claim related to β-galactosidase from <i>Kluyveromyces lactis</i> in Colief® and a reduction of gastrointestinal discomfort pursuant to Article 14 of Regulation (EC) No 1924/2006

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Following an application from Cross Vetpharm Group UK Ltd, submitted for authorisation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of the United Kingdom, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to β-galactosidase from Kluyveromyces lactis in Colief® and ...

Europe - EFSA - European Food Safety Authority EFSA Journal

21-7-2015

Modification of the existing maximum residue level for thiacloprid in Jerusalem artichokes

European Food Safety Authority In accordance with Article 6 of Regulation (EC) No 396/2005, the evaluating Member State (EMS), Belgium, compiled an application to modify the existing maximum residue level (MRL) for the active substance thiacloprid in Jerusalem artichokes. In order to accommodate for the intended use of thiacloprid Belgium proposed to raise the value of the existing MRL from the limit of quantification (LOQ) of 0.02 mg/kg to 0.05 mg/kg. Belgium drafted an evaluation repo...

Europe - EFSA - European Food Safety Authority EFSA Journal

21-7-2015

Biotin and contribution to normal energy-yielding metabolism: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Following an application from Specialised Nutrition Europe (formerly IDACE), submitted for authorisation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of France, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to biotin and contribution to normal energy-yielding metaboli...

Europe - EFSA - European Food Safety Authority EFSA Journal

21-7-2015

Niacin and contribution to normal energy-yielding metabolism: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Following an application from Specialised Nutrition Europe (formerly IDACE), submitted for authorisation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of France, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to niacin and contribution to normal energy-yielding metaboli...

Europe - EFSA - European Food Safety Authority EFSA Journal

31-7-2015

EXJADE (Deferasirox) Tablet, For Suspension [Novartis Pharmaceuticals Corporation]

Updated Date: Jul 31, 2015 EST

US - DailyMed

30-7-2015

CEFTRIAXONE Injection, Powder, For Solution [Sagent Pharmaceuticals]

Updated Date: Jul 30, 2015 EST

US - DailyMed

29-7-2015

News and press releases: Calls for civil society members for two EMA committees

Expressions of interest to represent civil society at PRAC and CAT to be submitted to European Commission by 30 September 2015

Europe - EMA - European Medicines Agency

28-7-2015

News and press releases: EMA to encourage use of scientific advice for post-authorisation safety studies

12-month pilot will support design of high-quality safety studies

Europe - EMA - European Medicines Agency

28-7-2015

EPSOM SALT (Magnesium Sulfate) Granule, For Solution [Vi-Jon]

Updated Date: Jul 28, 2015 EST

US - DailyMed

27-7-2015

News and press releases: Fast track routes for medicines that address unmet medical needs

Launch of two-month public consultations on revised guidelines on accelerated assessment and conditional marketing authorisation

Europe - EMA - European Medicines Agency

27-7-2015

PFIZERPEN (Penicillin G Potassium) Powder, For Solution [Roerig]

Updated Date: Jul 27, 2015 EST

US - DailyMed

24-7-2015

News and press releases: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 July 2015

Ten new medicines recommended for authorisation in the EU, and first malaria vaccine receives positive scientific opinion for use outside the EU

Europe - EMA - European Medicines Agency

24-7-2015

News and press releases: First malaria vaccine receives positive scientific opinion from EMA

Mosquirix to be used for vaccination of young children, together with established antimalarial interventions

Europe - EMA - European Medicines Agency

24-7-2015

News and press releases: Praluent recommended for approval to lower cholesterol

Medicine to offer therapy for patients unable to control high cholesterol with currently available treatment

Europe - EMA - European Medicines Agency

24-7-2015

News and press releases: EMA recommends approval of treatment for attention deficit hyperactivity disorder

Intuniv to be used in combination with comprehensive behavioural treatment in children and adolescents

Europe - EMA - European Medicines Agency

23-7-2015

News and press releases: Stimulating the development of medicines for children

EMA’s revision of class waiver list expected to push the exploration of many more medicines for use in children

Europe - EMA - European Medicines Agency

23-7-2015

CEFTRIAXONE Injection, Powder, For Solution [REMEDYREPACK INC. ]

Updated Date: Jul 23, 2015 EST

US - DailyMed

23-7-2015

BIVALIRUDIN Injection, Powder, Lyophilized, For Solution [Hospira, Inc.]

Updated Date: Jul 23, 2015 EST

US - DailyMed

22-7-2015

News and press releases: EU and Swiss regulators sign confidentiality arrangement

Arrangements will improve oversight of medicines for better protection of public and animal health

Europe - EMA - European Medicines Agency

22-7-2015

PIPERACILLIN AND TAZOBACTAM Injection, Powder, For Solution [Mylan Institutional LLC]

Updated Date: Jul 22, 2015 EST

US - DailyMed

Other products with the same active ingredient